Scientific publications for BioPredictive non-invasive diagnostics

Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.

4/435 Matches for
“Glycan”

“Glycan” Clear all

  1. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease. Key publication

    Peta V et al. · Clin Res Hepatol Gastroenterol · 2020 Match 100

    ### Background Haptoglobin bifucosylated tetra-antennary glycan have been identified in patients with…

    ActiTest FibroTest Alcohol HBV +2

  2. Altered serum N-glycomics in chronic hepatitis B patients.

    Gui HL et al. · Liver Int · 2010 Match 88

    …Our present study aimed to evaluate the use of serum glycan markers…

    FibroTest HBV

  3. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

    Callewaert N et al. · Nat Med · 2004 Match 75

    We applied our 'clinical glycomics' technology, based on DNA sequencer/fragment analyzers…

    FibroTest Alcohol Other

  4. Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.

    Gangadharan B et al. · PLoS One · 2012 Match 63

    ### Background Liver biopsy is the reference standard for assessing liver fibrosis and…

    FibroTest HCV

Showing the full result list. The page is server-rendered and not paginated.